The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials

Background: Eye tracking (ET) is a powerful methodology for studying attentional processes through quantification of eye movements. The precision, usability, and cost-effectiveness of ET render it a promising platform for developing biomarkers for use in clinical trials for autism spectrum disorder...

Full description

Bibliographic Details
Main Authors: Atyabi, A. (Author), Barney, E.C (Author), Bernier, R. (Author), Chang, S.A (Author), Charwaska, K. (Author), Dawson, G. (Author), Dommer, K.J (Author), Dziura, J. (Author), Faja, S. (Author), Hasselmo, S. (Author), Helleman, G. (Author), Jeste, S.S (Author), Johnson, S.P (Author), Kim, M. (Author), Levin, A.R (Author), Li, B. (Author), McAllister, T. (Author), McPartland, J.C (Author), Murias, M. (Author), Naples, A.J (Author), Nelson, C.A (Author), Sabatos-DeVito, M. (Author), Senturk, D. (Author), Seow, H. (Author), Shic, F. (Author), Sugar, C.A (Author), Wang, Q. (Author), Webb, S.J (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher